Bioadaptives Stock Probability of Future Pink Sheet Price Finishing Over 0.1
| BDPT Stock | USD 0.10 0.06 150.00% |
BioAdaptives |
BioAdaptives Target Price Odds to finish over 0.1
The tendency of BioAdaptives Pink Sheet price to converge on an average value over time is a known aspect in finance that investors have used since the beginning of the stock market for forecasting. However, many studies suggest that some traded equity instruments are consistently mispriced before traders' demand and supply correct the spread. One possible conclusion to this anomaly is that these stocks have additional risk, for which investors demand compensation in the form of extra returns.
| Current Price | Horizon | Target Price | Odds to move above the current price in 90 days |
| 0.10 | 90 days | 0.10 | near 1 |
Based on a normal probability distribution, the odds of BioAdaptives to move above the current price in 90 days from now is near 1 (This BioAdaptives probability density function shows the probability of BioAdaptives Pink Sheet to fall within a particular range of prices over 90 days) .
Given the investment horizon of 90 days the pink sheet has the beta coefficient of 95.0 suggesting as the benchmark fluctuates upward, the company is expected to outperform it on average. However, if the benchmark returns are projected to be negative, BioAdaptives will likely underperform. In addition to that BioAdaptives has an alpha of 294.2126, implying that it can generate a 294.21 percent excess return over Dow Jones Industrial after adjusting for the inherited market risk (beta). BioAdaptives Price Density |
| Price |
Predictive Modules for BioAdaptives
There are currently many different techniques concerning forecasting the market as a whole, as well as predicting future values of individual securities such as BioAdaptives. Regardless of method or technology, however, to accurately forecast the pink sheet market is more a matter of luck rather than a particular technique. Nevertheless, trying to predict the pink sheet market accurately is still an essential part of the overall investment decision process. Using different forecasting techniques and comparing the results might improve your chances of accuracy even though unexpected events may often change the market sentiment and impact your forecasting results.BioAdaptives Risk Indicators
For the most part, the last 10-20 years have been a very volatile time for the stock market. BioAdaptives is not an exception. The market had few large corrections towards the BioAdaptives' value, including both sudden drops in prices as well as massive rallies. These swings have made and broken many portfolios. An investor can limit the violent swings in their portfolio by implementing a hedging strategy designed to limit downside losses. If you hold BioAdaptives, one way to have your portfolio be protected is to always look up for changing volatility and market elasticity of BioAdaptives within the framework of very fundamental risk indicators.α | Alpha over Dow Jones | 294.21 | |
β | Beta against Dow Jones | 95.00 | |
σ | Overall volatility | 0.02 | |
Ir | Information ratio | 0.12 |
BioAdaptives Alerts and Suggestions
In today's market, stock alerts give investors the competitive edge they need to time the market and increase returns. Checking the ongoing alerts of BioAdaptives for significant developments is a great way to find new opportunities for your next move. Suggestions and notifications for BioAdaptives can help investors quickly react to important events or material changes in technical or fundamental conditions and significant headlines that can affect investment decisions.| BioAdaptives is way too risky over 90 days horizon | |
| BioAdaptives has some characteristics of a very speculative penny stock | |
| BioAdaptives appears to be risky and price may revert if volatility continues | |
| BioAdaptives has high likelihood to experience some financial distress in the next 2 years | |
| BioAdaptives currently holds 450.26 K in liabilities. BioAdaptives has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioAdaptives until it has trouble settling it off, either with new capital or with free cash flow. So, BioAdaptives' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioAdaptives sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioAdaptives to invest in growth at high rates of return. When we think about BioAdaptives' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 19.78 K. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 10.11 K. | |
| BioAdaptives currently holds about 49.58 K in cash with (158.65 K) of positive cash flow from operations. | |
| Latest headline from gurufocus.com: Blue Star Foods Announces Stock Buyback Program for Up to 1.5 Million |
BioAdaptives Price Density Drivers
Market volatility will typically increase when nervous long traders begin to feel the short-sellers pressure to drive the market lower. The future price of BioAdaptives Pink Sheet often depends not only on the future outlook of the current and potential BioAdaptives' investors but also on the ongoing dynamics between investors with different trading styles. Because the market risk indicators may have small false signals, it is better to identify suitable times to hedge a portfolio using different long/short signals. BioAdaptives' indicators that are reflective of the short sentiment are summarized in the table below.
| Common Stock Shares Outstanding | 20.4 M | |
| Cash And Short Term Investments | 83.1 K |
BioAdaptives Technical Analysis
BioAdaptives' future price can be derived by breaking down and analyzing its technical indicators over time. BioAdaptives Pink Sheet technical analysis helps investors analyze different prices and returns patterns as well as diagnose historical swings to determine the real value of BioAdaptives. In general, you should focus on analyzing BioAdaptives Pink Sheet price patterns and their correlations with different microeconomic environments and drivers.
BioAdaptives Predictive Forecast Models
BioAdaptives' time-series forecasting models is one of many BioAdaptives' pink sheet analysis techniques aimed to predict future share value based on previously observed values. Time-series forecasting models are widely used for non-stationary data. Non-stationary data are called the data whose statistical properties, e.g., the mean and standard deviation, are not constant over time, but instead, these metrics vary over time. This non-stationary BioAdaptives' historical data is usually called time series. Some empirical experimentation suggests that the statistical forecasting models outperform the models based exclusively on fundamental analysis to predict the direction of the pink sheet market movement and maximize returns from investment trading.
Things to note about BioAdaptives
Checking the ongoing alerts about BioAdaptives for important developments is a great way to find new opportunities for your next move. Our stock alerts and notifications screener for BioAdaptives help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.
| BioAdaptives is way too risky over 90 days horizon | |
| BioAdaptives has some characteristics of a very speculative penny stock | |
| BioAdaptives appears to be risky and price may revert if volatility continues | |
| BioAdaptives has high likelihood to experience some financial distress in the next 2 years | |
| BioAdaptives currently holds 450.26 K in liabilities. BioAdaptives has a current ratio of 0.04, indicating that it has a negative working capital and may not be able to pay financial obligations when due. Debt can assist BioAdaptives until it has trouble settling it off, either with new capital or with free cash flow. So, BioAdaptives' shareholders could walk away with nothing if the company can't fulfill its legal obligations to repay debt. However, a more frequent occurrence is when companies like BioAdaptives sell additional shares at bargain prices, diluting existing shareholders. Debt, in this case, can be an excellent and much better tool for BioAdaptives to invest in growth at high rates of return. When we think about BioAdaptives' use of debt, we should always consider it together with cash and equity. | |
| The entity reported the previous year's revenue of 19.78 K. Net Loss for the year was (1.05 M) with profit before overhead, payroll, taxes, and interest of 10.11 K. | |
| BioAdaptives currently holds about 49.58 K in cash with (158.65 K) of positive cash flow from operations. | |
| Latest headline from gurufocus.com: Blue Star Foods Announces Stock Buyback Program for Up to 1.5 Million |
Additional Tools for BioAdaptives Pink Sheet Analysis
When running BioAdaptives' price analysis, check to measure BioAdaptives' market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy BioAdaptives is operating at the current time. Most of BioAdaptives' value examination focuses on studying past and present price action to predict the probability of BioAdaptives' future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move BioAdaptives' price. Additionally, you may evaluate how the addition of BioAdaptives to your portfolios can decrease your overall portfolio volatility.